Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 17 Beta Acetoxy 9 Fluoro 11 Beta Hydroxyprogesterone
2. 17 Beta-acetoxy-9-fluoro-11 Beta-hydroxyprogesterone
3. Acetate, Flugestone
4. Acetate, Fluorogestone
5. Acetate, Flurogestone
6. Beta-acetoxy-9-fluoro-11 Beta-hydroxyprogesterone, 17
7. Beta-hydroxyprogesterone, 17 Beta-acetoxy-9-fluoro-11
8. Cronolone
9. Flugestone
10. Flugestone Acetate
11. Fluorogestone Acetate
12. Flurogestone
1. 2529-45-5
2. Flugestone 17-acetate
3. Fluorogestone Acetate
4. Flugestone Acetate
5. Flurogestone Acetate [usan]
6. Sc-9880
7. Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11b)-
8. [(8s,9r,10s,11s,13s,14s,17r)-17-acetyl-9-fluoro-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] Acetate
9. Chebi:79932
10. Nsc-65411
11. Gyncro-mate
12. 9-fluoro-11beta,17-dihydroxypregn-4-ene-3,20-dione 17-acetate
13. X60881643x
14. Flurogestone Acetate (usan)
15. Synchro-mate
16. Fga
17. Fluorogesterone Acetate
18. Nsc 65411
19. Unii-x60881643x
20. Ncgc00160534-01
21. Einecs 219-776-9
22. Brn 3123549
23. Dsstox_cid_26210
24. Dsstox_rid_81438
25. Dsstox_gsid_46210
26. 4-08-00-02904 (beilstein Handbook Reference)
27. Schembl281972
28. 9alpha-fluoro-11-hydroxy,17alpha-acetoxy Progesterone
29. Chembl2106773
30. Dtxsid6046210
31. Flurogestone Acetate [mi]
32. Flugestone Acetate [mart.]
33. Zinc4213372
34. Tox21_111878
35. Akos015896293
36. Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11.beta.)-
37. Am84839
38. Flurogestone Acetate [green Book]
39. Cas-2529-45-5
40. D04235
41. 529f455
42. A817767
43. Q5462900
44. 9alpha-fluoro-11-hydroxy,17alpha-acetoxyprogesterone
45. (11beta)17-(acetyloxy)-9-fluoro-11-hydroxypregn-4-ene-3,20-dione
46. 9-fluoro-11.beta.,17-dihydroxypregn-4-ene-3,20-dione 17-acetate
47. Pregn-4-ene-3,20-dione, 17-(acetyloxy)-9-fluoro-11-hydroxy-, (11beta)-
48. Pregn-4-ene-3,20-dione, 9-fluoro-11-beta,17-dihydroxy-, 17-acetate
49. [(8s,9r,10s,11s,13s,14s,17r)-17-ethanoyl-9-fluoranyl-10,13-dimethyl-11-oxidanyl-3-oxidanylidene-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] Ethanoate
50. Acetic Acid [(8s,9r,10s,11s,13s,14s,17r)-17-acetyl-9-fluoro-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] Ester
Molecular Weight | 406.5 g/mol |
---|---|
Molecular Formula | C23H31FO5 |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 406.21555225 g/mol |
Monoisotopic Mass | 406.21555225 g/mol |
Topological Polar Surface Area | 80.7 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 820 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Progestins
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)
ABOUT THIS PAGE
A Flurogestone Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flurogestone Acetate, including repackagers and relabelers. The FDA regulates Flurogestone Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flurogestone Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flurogestone Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flurogestone Acetate supplier is an individual or a company that provides Flurogestone Acetate active pharmaceutical ingredient (API) or Flurogestone Acetate finished formulations upon request. The Flurogestone Acetate suppliers may include Flurogestone Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Flurogestone Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Flurogestone Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Flurogestone Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Flurogestone Acetate GMP manufacturer or Flurogestone Acetate GMP API supplier for your needs.
A Flurogestone Acetate CoA (Certificate of Analysis) is a formal document that attests to Flurogestone Acetate's compliance with Flurogestone Acetate specifications and serves as a tool for batch-level quality control.
Flurogestone Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Flurogestone Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Flurogestone Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Flurogestone Acetate EP), Flurogestone Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flurogestone Acetate USP).
LOOKING FOR A SUPPLIER?